(Alpharetta, GA, October 26, 2015) – Cartiva, Inc., a developer of innovative solutions for the treatment of cartilage damage, osteoarthritis and other musculoskeletal conditions, announced that it has received GMP (Good Manufacturing Practices) certificaton from Brazil’s National Health Surveillance Agency (known

Share on LinkedInShare on FacebookShare on Google+Pin on PinterestEmail this to someone